Literature DB >> 30945684

Spectrum of X-linked intellectual disabilities and psychiatric symptoms in a family harbouring a Xp22.12 microduplication encompassing the RPS6KA3 gene.

Vera Uliana1, Francesco Bonatti, Valentina Zanatta, Paola Mozzoni, Davide Martorana, Antonio Percesepe.   

Abstract

Microduplications of the X chromosome are a rare cause of X-linked intellectual disability (XLID), a clinically and genetically heterogeneous spectrum of disorders. In the present study, a 950-kb Xp22.12 microduplication including the RPS6KA3 gene was detected in affected members of a family, including the proband (male), his mother and one maternal uncle. Four female carriers had major depression and one of them also had mild intellectual disability. The present and previous cases with overlapping microduplications suggest that Xp22.12 microduplications can be included in the neuropsychiatric copy number variations.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30945684

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  17 in total

1.  Nonsense-mediated mRNA decay (NMD) mechanisms.

Authors:  Saverio Brogna; Jikai Wen
Journal:  Nat Struct Mol Biol       Date:  2009-02       Impact factor: 15.369

2.  Unipro UGENE: a unified bioinformatics toolkit.

Authors:  Konstantin Okonechnikov; Olga Golosova; Mikhail Fursov
Journal:  Bioinformatics       Date:  2012-02-24       Impact factor: 6.937

Review 3.  Exploring the spectrum of 3-M syndrome, a primordial short stature disorder of disrupted ubiquitination.

Authors:  Peter E Clayton; Dan Hanson; Lucia Magee; Philip G Murray; Emma Saunders; Sayeda N Abu-Amero; Gudrun E Moore; Graeme C M Black
Journal:  Clin Endocrinol (Oxf)       Date:  2012-09       Impact factor: 3.478

4.  Maternal uniparental isodisomy and heterodisomy on chromosome 6 encompassing a CUL7 gene mutation causing 3M syndrome.

Authors:  K Sasaki; N Okamoto; K Kosaki; T Yorifuji; O Shimokawa; H Mishima; K-i Yoshiura; N Harada
Journal:  Clin Genet       Date:  2010-12-20       Impact factor: 4.438

5.  The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1.

Authors:  Dan Hanson; Philip G Murray; Amit Sud; Samia A Temtamy; Mona Aglan; Andrea Superti-Furga; Sue E Holder; Jill Urquhart; Emma Hilton; Forbes D C Manson; Peter Scambler; Graeme C M Black; Peter E Clayton
Journal:  Am J Hum Genet       Date:  2009-05-28       Impact factor: 11.025

6.  Exome sequencing identifies CCDC8 mutations in 3-M syndrome, suggesting that CCDC8 contributes in a pathway with CUL7 and OBSL1 to control human growth.

Authors:  Dan Hanson; Philip G Murray; James O'Sullivan; Jill Urquhart; Sarah Daly; Sanjeev S Bhaskar; Leslie G Biesecker; Mars Skae; Claire Smith; Trevor Cole; Jeremy Kirk; Kate Chandler; Helen Kingston; Dian Donnai; Peter E Clayton; Graeme C M Black
Journal:  Am J Hum Genet       Date:  2011-07-07       Impact factor: 11.025

7.  3-M syndrome: a novel CUL7 mutation associated with respiratory distress and a good response to GH therapy.

Authors:  A Deeb; O Afandi; S Attia; A El Fatih
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-04-01

8.  Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling.

Authors:  D Hanson; P G Murray; T Coulson; A Sud; A Omokanye; E Stratta; F Sakhinia; C Bonshek; L C Wilson; E Wakeling; S A Temtamy; M Aglan; E M Rosser; S Mansour; A Carcavilla; S Nampoothiri; W I Khan; I Banerjee; K E Chandler; G C M Black; P E Clayton
Journal:  J Mol Endocrinol       Date:  2012-10-30       Impact factor: 5.098

9.  3-M syndrome associated with growth hormone deficiency: 18 year follow-up of a patient.

Authors:  Cristina Meazza; Ekkehard Lausch; Sara Pagani; Elena Bozzola; Valeria Calcaterra; Andrea Superti-Furga; Margherita Silengo; Mauro Bozzola
Journal:  Ital J Pediatr       Date:  2013-03-21       Impact factor: 2.638

Review 10.  Mechanism and regulation of the nonsense-mediated decay pathway.

Authors:  Nele Hug; Dasa Longman; Javier F Cáceres
Journal:  Nucleic Acids Res       Date:  2016-01-14       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.